NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $107,000 | +28.9% | 4,600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $83,000 | -14.4% | 4,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $97,000 | -17.8% | 4,600 | -28.7% | 0.00% | 0.0% |
| Q3 2019 | $118,000 | -48.7% | 6,450 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $230,000 | +6.0% | 6,450 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $217,000 | +1.9% | 6,450 | -0.2% | 0.00% | -33.3% |
| Q4 2018 | $213,000 | -89.4% | 6,462 | -80.4% | 0.00% | -84.2% |
| Q3 2018 | $2,010,000 | +24.8% | 32,965 | 0.0% | 0.02% | +18.8% |
| Q2 2018 | $1,610,000 | +177.6% | 32,965 | +503.5% | 0.02% | +166.7% |
| Q1 2018 | $580,000 | +168.5% | 5,462 | +51.2% | 0.01% | +200.0% |
| Q4 2017 | $216,000 | +151.2% | 3,612 | +0.3% | 0.00% | +100.0% |
| Q3 2017 | $86,000 | +22.9% | 3,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $70,000 | -17.6% | 3,600 | -0.7% | 0.00% | 0.0% |
| Q1 2017 | $85,000 | +8400.0% | 3,626 | +13846.2% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 26 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 26 | +44.4% | 0.00% | – |
| Q2 2016 | $1,000 | -99.8% | 18 | -99.9% | 0.00% | -100.0% |
| Q4 2015 | $561,000 | +53.7% | 33,286 | +0.1% | 0.01% | +25.0% |
| Q3 2015 | $365,000 | -13.1% | 33,269 | -0.9% | 0.00% | -20.0% |
| Q2 2015 | $420,000 | +13.5% | 33,558 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $370,000 | -28.3% | 33,558 | +0.9% | 0.00% | -33.3% |
| Q4 2014 | $516,000 | – | 33,269 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |